LH logo

Labcorp Holdings Inc. Stock Price

NYSE:LH Community·US$23.2b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 11 Fair Values set on narratives written by author

LH Share Price Performance

US$276.94
60.94 (28.21%)
6.0% undervalued intrinsic discount
US$294.65
Fair Value
US$276.94
60.94 (28.21%)
6.0% undervalued intrinsic discount
US$294.65
Fair Value
Price US$276.94
AnalystConsensusTarget US$294.65

LH Community Narratives

AnalystConsensusTarget·Updated narrative
Fair Value US$294.65 6.0% undervalued intrinsic discount

AI And Collaborations Will Transform Diagnostic Testing

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Recent LH News & Updates

Investors Interested In Labcorp Holdings Inc.'s (NYSE:LH) Earnings

Sep 16
Investors Interested In Labcorp Holdings Inc.'s (NYSE:LH) Earnings

Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72

Aug 19
Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72

Labcorp Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72

Jul 30
Labcorp Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72

Labcorp Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72

Jul 13
Labcorp Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72

Labcorp Holdings Inc. Key Details

US$13.5b

Revenue

US$9.7b

Cost of Revenue

US$3.8b

Gross Profit

US$3.0b

Other Expenses

US$763.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 28, 2025
Earnings per share (EPS)
9.19
Gross Margin
28.14%
Net Profit Margin
5.66%
Debt/Equity Ratio
66.4%

Labcorp Holdings Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Proven track record with adequate balance sheet.

1 Risk
3 Rewards

About LH

Founded
1995
Employees
65450
CEO
Adam Schechter
WebsiteView website
www.labcorp.com

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 1.2%
  • 3 Months: 7.7%
  • 1 Year: 17.9%
  • Year to Date: 14.9%
The market has climbed 1.2% in the last 7 days, lead by the Information Technology sector with a gain of 2.4%. The market is up 18% over the last 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›